Status:
UNKNOWN
The Effect of Early Dyadic Psychotherapy for Mothers Suffering From PPD on Oxytocin Level and on Childrens' Emotional Development
Lead Sponsor:
HaEmek Medical Center, Israel
Conditions:
Postpartum Depression
Eligibility:
All Genders
3+ years
Phase:
NA
Brief Summary
Background: Postpartum depression follows approximately 10-15% of deliveries. Maternal functional disability, particularly in the relationship with the infant, a hallmark of PPD, causes impairment in ...
Detailed Description
Background: Postpartum depression follows approximately 10-15% of deliveries. Maternal functional disability, particularly in the relationship with the infant, a hallmark of PPD, causes impairment in ...
Eligibility Criteria
Inclusion
- women age 18 years old +
- women screening score of Depression EPDS\>10 (Edinburgh quastionnnaire)
- single child delivery
- babies 3-8 monthes years old
Exclusion
- severe MDD
- intelectual disability
- women screening score of Depression EPDS\<10 (Edinburgh quastionnnaire)
- pregnant women
- women diagnosed with Bipolar disorder or Schizophrenia, delirium, psychosis \*due to drug abuse, OCD
- Aggressive intentions towards the baby
- high risk for self and other injury
- drug abuse
- physical condition influencing depressive symptoms
- unstable physical condition due to various illnesses (cancer, diabetes...)
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04138368
Start Date
January 1 2020
End Date
December 1 2021
Last Update
March 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ilanir shchori
Afula, Israel